You are here: Industry Insights > IVD

News List

Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022 prnasia
January 29, 2022
Leading China-based biotech company Vazyme (688105.SH) participated in the 2022 edition of Medlab Middle East in the Dubai World Trade Centre (DWTC) from January 24th to 27th...
IVD industry must be supported in COVID-19 recovery strategy, says BIVDA pharmatimes
September 18, 2020
Ahead of the upcoming comprehensive spending review, The British In Vitro Diagnostics Association (BIVDA) has called for more support for the UK in vitro diagnostics (IVD) industry.
Huakang Biomed Holdings announces its share offering biospectrumasia
December 03, 2018
The Group offers mainly three categories of IVD reagents, namely, male fertility IVD reagent, parasite antibody detection reagent and EBV antibody detection reagent
Paradigm Shifts in Asia Healthcare Ecosystem Drive Future of IVD Industry prnasia
September 01, 2017
Paradigm shifts in the Asian healthcare ecosystem are driving the future of the IVD industry with stellar growth rates and rampant uptake of innovative technologies
In Vitro Diagnostics (IVD) quality control products market is expected to reach $1,052 million by 20 pharmaasia
February 09, 2017
The global IVD quality control products market is expected to reach $1,052 million by 2022, registering a CAGR of 3.5% from 2016 to 2022.